Compounds > tetrabutylammonium tetrafluoroborate
Page last updated: 2024-11-06
tetrabutylammonium tetrafluoroborate
Description
Tetrabutylammonium tetrafluoroborate (TBABF4) is a common ionic liquid, typically used as a supporting electrolyte in electrochemical studies. It is often employed in the synthesis of organic compounds and electrochemistry, as it is a non-corrosive and non-toxic salt that is soluble in a wide range of solvents. TBABF4 is typically synthesized through the reaction of tetrabutylammonium bromide with sodium tetrafluoroborate. Its properties, including its high conductivity, low viscosity, and wide electrochemical window, make it a suitable choice for various electrochemical applications, particularly in the study of battery performance and electrodeposition processes. The compound is also used in the synthesis of organic compounds, such as polymers, as it can act as a catalyst or phase transfer agent. TBABF4 has found application in the development of new ionic liquids for energy storage, sensor technologies, and other applications, highlighting its importance in contemporary research. The compound is often investigated for its ability to improve the performance of electrochemical devices and processes.'
tetrabutylammonium tetrafluoroborate: forms a fluoride-releasing resin when used with bis-GMA [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 67932 |
CHEMBL ID | 1078071 |
SCHEMBL ID | 15098 |
MeSH ID | M0231128 |
Synonyms (30)
Synonym |
AKOS015832947 |
tetrabutylammonium tetrafluoroborate |
tetrabutylammonium fluoroborate |
AC-11053 |
429-42-5 |
T2648 |
T0914 |
CHEMBL1078071 |
tetrabutyl ammonium tetrafluoroborate |
1-butanaminium, n,n,n-tributyl-, tetrafluoroborate(1-) (1:1) |
1-butanaminium, n,n,n-tributyl-, tetrafluoroborate(1-) |
einecs 207-058-8 |
tetra-n-butylammonium tetrafluoroborate |
FT-0632123 |
tetra(but-1-yl)ammonium tetrafluoroborate;tetra-n-butylammonium fluoroborate;tetra-n-butylammonium tetrafluoroborate;tetrabutylammonium fluoroborate;tetrabutylammonium tetrafluoroborate |
SC10017 |
SCHEMBL15098 |
DTXSID7059983 |
NNZZSJSQYOFZAM-UHFFFAOYSA-N |
tetra-n-butyl ammonium fluoroborate |
mfcd00011634 |
tetrabutylammonium fluoborate |
tetrabutylammoniumtetrafluoroborate |
F13072 |
tetrabutylazanium;tetrafluoroborate |
tetrabutylazanium; tetrafluoroboranuide |
AS-11610 |
tetrabutyl-ammonium tetrafluoroborate |
EN300-113213 |
tetra(but-1-yl)ammonium tetrafluoroborate |
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
AID470206 | Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 assessed as ratio of maximum zone of inhibition to concentration required to reach half maximum zone of inhibition after 24 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| Development of a novel expression, ZI MAX/K ZI, for determination of the counter-anion effect on the antimicrobial activity of tetrabutylammonium salts. |
AID470205 | Antimicrobial activity against Escherichia coli K-12 C600 assessed as ratio of maximum zone of inhibition to concentration required to reach half maximum zone of inhibition after 24 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| Development of a novel expression, ZI MAX/K ZI, for determination of the counter-anion effect on the antimicrobial activity of tetrabutylammonium salts. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 37.32
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 37.32 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.82 (4.65) | Search Engine Demand Index | 46.54 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |